Early Signal logo Early Signal - AI Powered Portfolio
Limited stock view: advanced signal, recommendation, portfolio, and history details are locked for guests.

AMGN

Amgen Inc.
Layer 8: AI-Enabled Transformation Ai Pharma Biotech Mega Cap Options
NEUTRAL none conviction daily run

Guest preview — showing qualitative direction only.

$206.4B
Market Cap
47%
AI Revenue
$1105.5M
Avg Daily Vol
0
Sec. Layers

AMGN Analysis Summary

Amgen Inc. (AMGN) operates in Layer 8: AI-Enabled Transformation, in the Ai Pharma Biotech sub-sector. With a $206.4B market cap and 47% AI-derived revenue, it sits in the downstream tier of the AI supply chain.

The current composite signal is neutral with none conviction, driven primarily by daily factors.

Learn more about our signal methodology. View Signal History →

Analysis as of May 26, 2026 20:02 UTC (daily run). Live data.

Data Trust

Quality grade C · Score 0.74 · Updated May 26, 2026 20:02 UTC (27.0h ago)

Source-by-source provenance available after sign-in.

Signal Snapshot

Current model view is neutral with none conviction. Based on the latest daily run.

Primary driver appears to be daily factors for this ticker.

Latest Recommendation (Guest Preview)

SELL low conviction tactical sleeve

Low bearish on Amgen Inc. (AI-Enabled Transformation, 47% AI revenue). Signal: -0.15.

Why Not a Buy?

No signal data available for this ticker yet.

Supply Chain Position

Sign in to unlock upstream/downstream signal map and relationship context. .

Portfolio Position

Sign in to unlock current target weights, sleeve placement, and conviction. .

Bottleneck Exposure (Guest Preview)

No active bottleneck exposure is currently flagged for this ticker.

Fundamentals & Characteristics

Market Cap
$206,393M (206.4B)
Avg Daily Volume
$1105.5M
AI Revenue %
47%
Liquid Options
Yes
Layer
8 — AI-Enabled Transformation
Sub-Sector
Ai Pharma Biotech
Mega Cap
Yes

Latest Signal Snapshot

NEUTRAL none conviction daily May 26, 2026 20:02 UTC

Full multi-run history, trend charts, and component-level changes available after sign-in.

Key Facts About AMGN

AMGN FAQ

What does Amgen Inc. do in AI?

Amgen Inc. (AMGN) operates in the AI-Enabled Transformation layer of the AI supply chain, in the Ai Pharma Biotech sub-sector.

Is AMGN a buy or sell?

Full signal analysis for AMGN is available after sign-in at Early Signal. Our quantitative model analyzes momentum, sentiment, earnings, and supply chain factors.

What AI supply chain layer is AMGN in?

AMGN is in Layer 8: AI-Enabled Transformation. Early Signal's 10-layer taxonomy traces the AI value chain from raw materials (Layer 0) through semiconductor manufacturing, chips, infrastructure, cloud platforms, AI tools, foundation models, applications, AI-enabled transformation, to secondary beneficiaries (Layer 9). Learn more on the methodology page.

What is Amgen Inc.'s AI revenue exposure?

Amgen Inc. derives approximately 47% of its revenue from AI-related activities. It has a market capitalization of $206.4B and sits in the downstream tier of the AI supply chain.

Who are AMGN's AI supply chain partners?

AMGN does not have mapped upstream or downstream supply chain relationships in the current AI ecosystem model.

AI Brand Visibility

How often AI models (ChatGPT, Claude, Gemini) mention Amgen Inc. when users ask questions in its category.

Source: geo.sig.ai — tracks AI visibility for 5,600+ companies across 30 verticals.